Zscaler Unveils Industry-First Security Service Edge Innovations to Protect Enterprises from the Most Sophisticated Cyber Attacks
Advancements to the Most Deployed ZTNA Solution Strengthen the Zscaler Zero Trust Exchange with New…
Advancements to the Most Deployed ZTNA Solution Strengthen the Zscaler Zero Trust Exchange with New…
Dubai, United Arab Emirates–(Newsfile Corp. – March 22, 2022) – Top cryptocurrency exchange LBank’s CEO…
LONDON & DENVER–(BUSINESS WIRE)–AtlasEdge, a pan-European edge data centre provider, today confirmed the selection of…
Insta360 engineered their ONE RS action camera to connect to a 360° module, a weatherproof…
Platform will enable faster credit decisions and increased credit access across customer segments NEW YORK–(BUSINESS…
MELBOURNE, Australia and BRUSSELS, Belgium, March 22, 2022 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX:…
GUANGZHOU, China, March 21, 2022 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR, the…
MALVERN, Pa., March 21, 2022 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a clinical-stage biopharmaceutical company…
Announced during HIMSS 2022, Solodev now offers a serverless solution for enterprise-grade healthcare organizations to…
NEW YORK–(BUSINESS WIRE)–KKR Real Estate Finance Trust Inc. (“KREF”) (NYSE: KREF) today announced the tax…
LOUISVILLE, Ky.–(BUSINESS WIRE)–Humana Inc. (the “company”) (NYSE: HUM) announced today that it has priced a…
MELBOURNE, Australia–(BUSINESS WIRE)–#ReshapingCX–Alvaria and Call Design announce a new Alvaria Workforce customer, TSA Group. Australia’s…
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA assigns preliminary ratings to 24 classes of mortgage pass-through certificates from J.P….
Orphazyme A/SCompany announcementNo. 12/2022www.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, March 21, 2022 – Orphazyme A/S…
BILLERICA, Mass., March 21, 2022 (GLOBE NEWSWIRE) — SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ:…
FORT COLLINS, Colo., March 21, 2022 (GLOBE NEWSWIRE) — Statera Biopharma, Inc. (NASDAQ: STAB) (the…
– VRDN-002 incorporates clinically validated half-life extension technology to support development as a low volume…
Company to undergo a strategic portfolio review while continuing to execute on the development of…
On track to deliver topline proof-of-concept data from Phase 1 clinical trial of oral IL-17…
FOSTER CITY, Calif., March 21, 2022 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the…